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Abstract: Mounting evidence suggests that weight management and physical activ-
ity (PA) improve overall health and well being, and reduce the risk of morbidity and
mortality among cancer survivors. Although many opportunities exist to include
weight management and PA in routine cancer care, several barriers remain. This
review summarizes key topics addressed in a recent National Academies of Science,
Engineering, and Medicine workshop entitled, “Incorporating Weight Management
and Physical Activity Throughout the Cancer Care Continuum.” Discussions related
to body weight and PA among cancer survivors included: 1) current knowledge and
gaps related to health outcomes; 2) effective intervention approaches; 3) addressing
the needs of diverse populations of cancer survivors; 4) opportunities and challenges
of workforce, care coordination, and technologies for program implementation;
5) models of care; and 6) program coverage. While more discoveries are still needed
for the provision of optimal weight-management and PA programs for cancer survi-
vors, obesity and inactivity currently jeopardize their overall health and quality of life.
Actionable future directions are presented for research; practice and policy changes
required to assure the availability of effective, affordable, and feasible weight man-
agement; and PA services for all cancer survivors as a part of their routine cancer
care. CA Cancer J Clin 2017;000:000-000. VC 2017 American Cancer Society.
Keywords: nutrition, physical activity, supportive care, survivorship, weight
management
Introduction
With growing evidence of the association between obesity, excess weight, and can-
cer, the National Cancer Policy Forum (NCPF) of the National Academies of Sci-
ences, Engineering, and Medicine hosted a workshop in 2011 on the “Role of
Obesity in Cancer Survival and Recurrence.” That workshop examined epidemio-
logic evidence, biologic mechanisms, preclinical studies, and a limited number of
randomized controlled trials (RCTs) of interventions that promoted weight loss via
caloric restriction or increased physical activity (PA) in patients with cancer.1 Two
scientific papers emanated from this endeavor—one that was more mechanistic in
nature,2 and the other focused on translational research for patient care.3 Both
emphasized gaps in knowledge.
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Six years later, and after considerable advances in this
arena, including a position paper and campaign on obesity
and cancer issued by the American Society of Clinical
Oncology (ASCO),4 another NCPF workshop on obesity
and cancer was convened—this time focusing on translating
research findings into clinical practice and community-
based programs. That workshop, “Incorporating Weight
Management and Physical Activity Throughout the Cancer
Care Continuum,” also drew international experts, but with
greater emphasis on behavioral science, clinical research,
public policy, dissemination science, and health economics.
Workshop presentations and discussions examined the
available evidence regarding the value of promoting weight
management and PA across the period of cancer survivor-
ship, from diagnosis to end of life,5,6 along with evaluation
of opportunities and challenges in current approaches to
promote PA and weight management. To ensure that dis-
cussions would be patient-centered, the opening session of
the workshop featured 2 cancer survivors who shared their
experiences with cancer treatment, weight management,
and PA (for key excerpts, see Table 1). Also, throughout
the workshop, presentations and discussions illustrated the
broad spectrum of diversity among cancer survivors in terms
of cancer type, stage, molecular subtype, length of survivor-
ship, comorbidity and functional status, age, race/ethnicity,
gender, and geographic location that require consideration
in tailoring weight-management and PA interventions and
recognition that “one size does not fit all.” The workshop
culminated in a discussion of whether the strength of evi-
dence warranted the provision and coverage of services for
weight management and PA that are specifically directed
toward cancer survivors and ways to enhance the delivery of
these services to the growing sector of cancer survivors in
this nation, who currently number well over 15 million.7
Herein, we report a summary of the workshop presenta-
tions, discussions, and conclusions.
Body Weight, PA, and Health Outcomes for
Cancer Survivors: Knowledge and Gaps
This first section, which provides a foundation for the
remainder of the article, is devoted to critically evaluating
the state of knowledge regarding the relationship between
body weight or PA and health outcomes for cancer survi-
vors. It begins with an overview of the evidence on cancer
outcomes and then addresses other outcomes, such as
TABLE 1. Prioritizing Patient Voices
It is essential to hear and prioritize the voices of cancer survivors. Below are select statements from 2 patient advocates who, despite differing backgrounds,
diagnoses, and points in their survivorship journey, offer statements with common themes.
Karen Cochrane is a white, 53-year old nurse who was recently diagnosed with early stage breast cancer and is currently receiving chemotherapy. She is
concerned about her overall well being and is working toward reaching a healthy weight and being physically active.
Robert Harrison is a black, 72-year old, retired, businessman who was diagnosed with metastatic prostate cancer 14 years ago. Currently, he is actively
monitoring his cancer with his urologist. He has played an active role in his care and lost over 60 pounds, and he considers himself a cancer “thriver.”
Both voice their thoughts about weight management and physical activity during cancer treatment and beyond:
l “Understand that we are human systems, we are not just a disease to be treated.”
l “This isn’t just about surviving the treatment of cancer, it’s making sure I do everything I can to live a long healthy life.”
l “Weight Management and physical activity are essential components of the treatment of cancer patients and can be, should be, and must be integrated
into and monitored throughout treatment to help achieve the most beneficial treatment outcomes.”
l “You know they (patients) are going to gain weight. You know they (patients) are going to lose muscle. From the very beginning, integrate it into treatment,
so that we can minimize these negative impacts and maximize the opportunities to keep the body as healthy as possible.”
l “People need to be told how to lose weight and followed up. There needs to be a long-standing program and support.”
l “It would be most helpful, and dollars well spent, to provide programs and support to teach people how to make healthy food choices and how to be
physically active.”
l “It is not just providing some information or saying that you need to lose weight, it needs to be an ongoing, life-long process.”
l “It isn’t easy, because if it were we would all be normal weight and very active; but, with help and support, it can be done.”
l “What has helped me was to have a plan and follow-up.”
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quality of life (QOL) and fatigue. Finally, it identifies evi-
dence gaps addressed by ongoing and recent trials, gaps that
remain, and the opportunities to fill these gaps.
Overview of Obesity and Cancer Outcomes
Excess weight gain, overweight, and obesity are associated
with an increased risk of many cancers; recently, the Inter-
national Agency for Research on Cancer reported that there
is sufficient evidence to conclude that avoidance of excess
body fat is associated with a lower risk for cancers of the
endometrium, esophagus (adenocarcinoma), gastric cardia,
kidney (renal cell), multiple myeloma, meningioma, liver,
pancreas, colorectum, gallbladder, breast (postmenopausal),
ovary, and thyroid.8 There also is growing observational evi-
dence that obesity is associated with poorer cancer outcomes
among individuals with cancer. The largest body of evidence
relates to breast cancer. A meta-analysis of 82 studies
involving 213,075 women with breast cancer found a 41%
relative increase in all-cause mortality for women with obe-
sity versus those of normal weight (relative increases were
75% in premenopausal women and 34% in postmenopausal
women).9 That study also reported increased all-cause mor-
tality for overweight women, albeit the relative increases
were smaller. Another meta-analysis found that the risk of
mortality associated with overweight and obesity was similar
for patients with estrogen receptor (ER)-positive and ER-
negative breast cancer, although some (but not all) subse-
quent individual studies have suggested that the risk may be
present only in women with ER-positive disease.10 Among
breast cancer survivors treated with anthracyclines, obesity
also is associated with greater cardiotoxicity.11 Similarly,
adverse associations of obesity with survival are reported for
endometrial, prostatic, pancreatic, colorectal, and ovarian
cancer as well as some hematologic malignancies.3,4 In con-
trast, overweight and obesity are associated with somewhat
better outcomes in lung, esophageal, and kidney cancer—
cancers in which the morbidity of cachexia and advanced
stage at diagnosis are more common.12
The association of excess weight gain, overweight, and
obesity with cancer is biologically complex. Increased adi-
posity results in changes in adipose tissue, including death
of adipocytes, leading to infiltration of inflammatory cells,
as well as secretion of cytokines and other factors that stim-
ulate cancer cell growth, invasion, angiogenesis, and metas-
tasis.13 Increased adiposity also is associated with changes in
systemic physiology, including insulin resistance, dysglyce-
mia, altered adipokines, and increased inflammation;
together, these changes enhance signaling through key
growth pathways (eg, PI3K, RAS, JAK-STAT) and alter
cellular metabolism.2,14 These obesity-associated effects at
the tissue and physiologic levels invoke changes in many of
the hallmarks of cancer,15 including sustained proliferative
signaling, activated invasion and metastasis, induced angio-
genesis, and resistance to cell death.2 Overweight and obe-
sity also enable deregulation of cellular energetics and
tumor-promoting inflammation.2,15 While observational
data obtained from a multitude of studies, coupled with this
strong biologic rationale, provide strong support for an asso-
ciation of obesity with poor cancer outcomes, there is insuf-
ficient evidence to conclude that this association is causal.
Studies examining weight-related changes in the tran-
scriptome of breast cancers indicate that cancers developing
in women with obesity are biologically different from those
in women of normal weight in terms of altered gene regula-
tion and expression.16 At this time, it is unclear whether
reversal of obesity will lead to reversal of these differences or
lead to improved cancer outcomes. RCTs of weight loss or
pharmacologic interventions that reverse obesity-associated
changes related to overweight and obesity are needed.
Overview of the Evidence on Cancer Outcomes
Related to PA
Evidence linking increased PA to improved cancer out-
comes is preliminary but promising. A recent systematic
review and pooled analysis of 26 observational studies found
that cancer survivors who engaged in higher levels of PA
(>18 metabolic equivalent hours per week) had a 37% lower
risk of dying from cancer, compared with those who
engaged in lower levels of PA (<1.5 metabolic equivalent
hours per week; hazard ratio [HR], 0.63; 95% confidence
interval [95% CI], 0.54-0.73).17 This risk reduction is
remarkably consistent across breast, colorectal, and prostate
cancer survivors. There also is growing evidence that the
association between PA and cancer mortality varies by spe-
cific molecular or genetic markers, suggesting a possible pre-
cision medicine approach to exercise oncology (eg, a strong
inverse association between PA and colon cancer mortality
is noted for survivors whose tumors express p27 [HR, 0.32;
95% CI, 0.12-0.85]). In addition, the link between PA and
cancer outcomes has strong biologic plausibility related to
sex hormones, cell growth regulators, DNA damage repair,
inflammatory markers, immune function, and antioxidant
pathways.18
RCTs are needed to establish the causal effects of PA on
cancer outcomes. The Colon Health and Life-Long Exer-
cise Change (CHALLENGE) Trial is the first phase 3 trial
examining the effects of a 3-year structured PA program on
disease-free survival in patients with stage II and III colon
cancer who have recently completed chemotherapy.19 To
date, the trial has demonstrated feasibility in accrual20 and
PA behavior change21; it has randomized over 590 of the
planned 962 patients. The Intense Exercise for Survival
(INTERVAL) Trial is another phase 3 trial examining the
effects of a 2-year structured PA program on overall survival
CA CANCER J CLIN 2017;00:00–00
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in 866 men with metastatic, castrate-resistant prostate can-
cer.22 These trials, and others like them, will provide the
first definitive evidence on the role of PA in improving can-
cer outcomes.
Influence of Weight Management and PA on QOL
Outcomes
Although obtaining evidence of the impact of weight manage-
ment and PA on cancer progression and mortality is critical,
many cancer survivors experience significant comorbidities, or
cancer-related and treatment-related physical and psychosocial
problems that compromise their QOL.23 Healthy eating, reg-
ular PA, and maintaining a healthy weight have been recom-
mended for cancer survivors to prevent, mitigate, and manage
these downstream sequelae.24,25
Weight gain with concomitant loss of muscle (ie, sarco-
penic obesity) and bone are common after chemotherapy
and hormone therapy, placing cancer survivors at risk for
comorbidities, such as cardiovascular disease (CVD), diabe-
tes, second primary cancers, osteoporosis, and functional
decline.25,26 Research indicates that diet-induced and
exercise-induced weight management interventions can pro-
duce clinically meaningful weight loss in cancer survivors
within 6 months, resulting in improved blood lipids and
metabolic health and reduced inflammation.27-31 Also, sev-
eral studies have reported positive effects of targeted PA on
bone health,32-34 which is important because osteoporosis
and the risk of subsequent fractures is increased by 15% to
20% among cancer survivors who receive hormone treat-
ment for breast or prostate cancer.35
Growing numbers of studies have examined the effects of
PA on CVD in cancer survivors, with a meta-analysis indi-
cating that PA improves cardiorespiratory fitness—a power-
ful predictor of mortality.36,37 Growing evidence also
suggests that PA may improve cognitive function38 and
lessen peripheral neuropathy,39 lymphedema,40 and arthral-
gia41 in patients treated for cancer.
In 2010, the American College of Sports Medicine
(ACSM) published PA guidelines for cancer survivors based
on 85 PA trials conducted during or after treatment.24 The
systematic review and findings from 2 more recent meta-
analyses42,43 demonstrate that PA is safe and effective in
improving QOL, cancer-related fatigue, and physical func-
tion. While overall effect sizes are small, there is consistent
empirical evidence to support PA promotion as part of can-
cer care.42,43
Evidence Gaps and Ongoing Randomized Weight
Management and PA Trials in Cancer Survivors
Although many trials have evaluated the impact of weight
management and PA interventions on outcomes, such as
body composition, fitness, and QOL in cancer survivors,
critical gaps remain. Most notably, evidence from RCTs is
not yet available that weight management or increased PA
after cancer diagnosis will improve survival or reduce cancer
recurrence. The Women’s Intervention Nutrition Study,
conducted among 2437 women with early stage breast can-
cer, provides some of the only RCT data and suggests that a
mean nonprescribed weight loss of 6 pounds, resulting from
a fat-restricted diet, was associated with a significant
decrease in subsequent breast cancer events (local, regional,
and distant recurrence; ipsilateral breast recurrence after
lumpectomy; and contralateral breast cancer) compared with
a control arm (ie, 9.8% vs 12.4%; P 5 .034), a finding driven
by women diagnosed with ER-negative disease.44 However,
because the dietary fat intervention also led to weigh loss in
that study,45 it is impossible to disentangle whether the
low-fat diet or the weight loss was most responsible for can-
cer control. Other questions remain about the biologic path-
ways that underlie the relationship between weight
management and PA and malignancy; the relative contribu-
tion of body weight, diet, and/or PA to cancer outcomes;
the optimal timing, dose, and duration of weight manage-
ment and PA interventions; and the best ways of imple-
menting weight management and PA interventions in
diverse cancer populations.44 Moreover, the science regard-
ing cancer outcomes and sedentary time also needs to be
further developed, as well as the evaluation of potential
interventions to limit sedentary time.
Several ongoing trials aim to address these evidence gaps
(see Table 2).19,46-48 Each of the ongoing studies examines
the impact of weight loss or increased PA, either alone or in
combination with improvements in diet quality, on cancer
recurrence, cancer-related mortality, or overall survival in
individuals diagnosed with a single malignancy. None of the
studies compares the effects of different weight manage-
ment or PA interventions or of different doses or durations
of intervention. one-half of the trials enroll breast cancer
survivors, and the majority focus on those with no evidence
of active disease.
Although these trials will provide critical information
regarding the role of weight management and PA in the
management of cancer survivors, several gaps will remain.
Given that each trial focuses on the effect of a particular
weight management or PA intervention in a specific cancer
survivor population, it will be difficult to generalize the
information gained from these studies across all cancer sur-
vivors or to other types of interventions. Moreover, from a
feasibility and economic standpoint, it is unlikely that there
ever will be trials conducted to evaluate the effect of each
type of weight management and PA intervention on every
malignancy. So, how do we bridge these evidence gaps and
ensure that all cancer survivors have access to weight man-
agement and PA interventions that could reduce the risk of
Weight Management and Physical Activity Throughout the Cancer Care Continuum
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recurrence and improve survival after a cancer diagnosis?
Part of the key to expanding knowledge gained from ongo-
ing individual trials comes from the correlative science that
is embedded in each and the potential to pool data and sam-
ples across smaller studies. By evaluating the effect of weight
management and PA interventions on blood-based bio-
markers (and extant tumor tissue) and determining the rela-
tionship between changes in markers, such as insulin and
C-reactive protein, and cancer recurrence and survival,
intermediate biomarkers could be established to inform
future research,3 akin to research in CVD, in which trials
are powered to examine changes in blood pressure or lipid
levels rather than on clinical endpoints, such as myocardial
infarction.49 Correlative science also could discover predic-
tive markers of response and determine which cancer survi-
vor populations are most likely to derive benefit from
specific interventions.
Summary
Ongoing trials will provide vital information on weight
management and PA interventions with and without
improvements in diet quality on cancer recurrence and sur-
vival, but several important knowledge gaps will remain.
Biomarker analyses offer the potential to extend the knowl-
edge gained from these trials to other patient populations
and could ultimately determine the components of optimal
interventions and how they are best applied in a personal-
ized medicine approach to improve cancer outcomes. While
more research is needed to elucidate the impact of weight
management and PA on cancer-specific outcomes, it is
important to note that ASCO now recommends discussion
about weight management, including dietary and PA
changes, among oncology providers and their patients.4
This recommendation stems from solid evidence that diet,
PA, and reduced adiposity play critical roles in preventing
CVD and diabetes and exert a positive influence on QOL,
physical function, and fatigue.
Effective Approaches for Improving Weight
Management and PA
Large RCTs related to weight loss and the control of
chronic conditions, such as diabetes, have provided suffi-
cient evidence to warrant changes in weight management
recommendations from the US Preventive Services Task
Force (USPSTF) and from professional organizations.4,50-53
Research evidence on the benefits of PA (including aerobic,
resistance training, and flexibility and coordination) has sig-
nificantly expanded. Currently, the Physical Activity Guide-
lines Advisory Committee is preparing a scientific report
with a scheduled release date of early 2018. This evidence
has contributed to the development of weight management
and PA interventions for cancer survivors and RCTs to
evaluate the impact on important short-term and longer
term outcomes in cancer survivors, such as QOL, tolerance
for cancer therapy, comorbidity, and disease-free survival.
Long-term evidence from previous weight loss and PA trials
has demonstrated repeatedly that a high proportion of trial
participants have difficulty maintaining behavior changes
outside the context of a clinical trial, in part because the cur-
rent US environment provides little support for being physi-
cally active or eating a healthy diet. This recognition has led
to an increase in research examining the environmental, pol-
icy, and systems changes needed to help individuals adopt
and maintain recommended behaviors.
Interventions for Weight Management in Other
Populations That Are Applicable to Cancer
Survivors
Lifestyle modifications to alter eating behaviors and increase
PA are the cornerstone of treatment for overweight and
obesity and have been used successfully in several large-scale
trials. The American College of Cardiology (ACC), the
American Heart Association (AHA), and The Obesity
Society (TOS) reviewed the results from these RCTs and
concluded within the 2013 Guidelines for the Treatment of
Obesity that adherence to a calorically restricted diet pre-
dicts weight loss success, independent of the type of diet or
macronutrient composition.54 The guidelines also recom-
mend using body mass index (BMI) and waist circumfer-
ence to advise patients of their risk of developing other
comorbidities and to prescribe a set number of calories
(kcal) per day according to the following: 1200 to 1500 kcal
per day for women and 1500 to 1800 kcal per day for men
to promote a 1-pound to 2-pound weight loss per week.54 A
sustained weight loss of as little as 3% to 5% of initial body
weight reduces the risk of type II diabetes and risk factors
for CVD.54
The Look AHEAD (Action for Health in Diabetes)55
and Diabetes Prevention Program (DPP)56 trials are 2 of
the most successful long-term studies to illustrate the ability
of lifestyle interventions to reduce and maintain body
weight and reduce the risk of chronic diseases; both were
instrumental in informing the 2013 AHA/ACC/TOS obe-
sity treatment guidelines. The lifestyle interventions in these
2 trials were similar (ie, low-fat, low-calorie diet with the
use of meal replacements and 150-175 minutes per week of
moderate-to-vigorous–intensity PA).
Subsequently, some studies have demonstrated that
higher protein diets (1.2-1.6 g protein/kg of body weight
per day) provide benefits beyond weight loss and may pre-
serve lean body mass (LBM), especially in older men and
women.57,58 Resistance training also has been shown to be
particularly beneficial in older adults, including breast and
prostate cancer survivors, to preserve LBM and bone health,
Weight Management and Physical Activity Throughout the Cancer Care Continuum
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maintain a higher resting metabolic rate, preserve physical
functioning, and reduce falls and injury).59-61
Successful long-term weight management requires several
behavioral strategies.62 Tactics for weight success include:
maintaining a low-fat, low-calorie dietary pattern; limiting
dietary variety; eating breakfast most days of the week; daily
to weekly weighing; performing 2500 kcal per week of PA
(eg, brisk walking for approximately 1 hour per day); and
reducing television watching.
Interventions for PA in Other Populations That are
Applicable to Cancer Survivors
Over the past few decades, numerous studies have clearly
shown that PA of sufficient volume and intensity reduces
the risk of several chronic diseases and improves physical
function.63 More recently, research has started to examine
the impact of physical inactivity on overall morbidity and
mortality.64-66
Aerobic PA of sufficient volume and intensity (“exercise”)
to improve cardiorespiratory fitness, which is a potent bio-
marker of morbidity and all-cause mortality, needs to be
frontline care in both healthy and cancer survivor popula-
tions.67-69 Consistent aerobic exercise can delay the onset
of disability by more than 10 years and markedly increases
survival among older adults with projected lifespans of at
least 20 years (the length of survivorship that burgeoning
numbers of cancer survivors are now achieving).7,70 Among
cancer survivors, data indicate that high versus low cardiore-
spiratory fitness reduces the risk of mortality by 45%.71
Likewise, resistance PA of sufficient volume and intensity
(“exercise”) to increase neuromuscular fitness (ie, LBM,
strength, power, fatigue resistance) is key to frontline care.
Low LBM is a major predictor of all-cause mortality and
physical disability.72 Resistance exercise has repeatedly been
shown to improve neuromuscular fitness and skeletal health
and to reduce the risk of disability.73,74
Although the molecular underpinnings of PA-driven
health benefits have not been fully elucidated, significant
progress has been made,75 and more information will be
gleaned via the National Institutes of Health (NIH)-funded
Molecular Transducers of Physical Activity Consortium
(MoTrPAC), which is charged with mapping molecular
responses to aerobic and resistance exercise to more fully
understand the cellular and molecular signals that drive
potential health benefits. This vital step will enable a preci-
sion medicine approach and the individualization of exercise
prescriptions.63,75
Interventions for Weight Management in Cancer
Survivors
Data indicate that weight loss can be promoted among can-
cer survivors who are overweight or have obesity.31,76
Sentinel studies of weight management are summarized in
Table 327-30,77-95 and generally rely on cornerstone elements
of weight loss (ie, dietary modification to promote caloric
restriction, increased PA, and behavior modification).
Nonetheless, there are acknowledged limitations to this
research (eg, brief study periods, lack of repeated and objec-
tive measures [including body composition outcomes], and
overrepresentation of breast cancer survivors who may be
“worried, white, and well”). Many questions remain within
the context of well-designed and controlled efficacy trials
(eg, intervention timing, inclusion of sleep hygiene or stress
management components, and discerning the full impact
of weight loss across a broad range of symptoms and condi-
tions). Discovery is needed to inform personalized
medicine-based approaches and thereby elucidate molecular
and metabolic predictors important for tailoring weight loss
regimens for individual patients in terms of dose and opti-
mal macronutrient distribution. In addition, there is a need
for pragmatic interventions that can overcome well known
barriers imposed by distance, economics, co-occurring med-
ical conditions, and culture. The diversity of needs among
cancer survivors, many of whom are older, increases the
urgency of pragmatic trials to test and compare both high-
touch/more-effect approaches and lower-touch/less-burden
approaches. Well-designed research across the spectrum
requires broad representation by cancer-type, age, sex, and
race/ethnicity as well as sufficient sample sizes to conduct
subgroup analyses. Ideally, interventions need to be
designed with the input of oncologists, dietitians, exercise
specialists, behavioral scientists, statisticians, software spe-
cialists (if needed), community stakeholders, and, most
important of all, cancer survivors. The input of health econ-
omists also is key to developing programs that are sustain-
able and can be widely disseminated.
Interventions to Improve PA in Cancer Survivors
Various PA interventions have been evaluated in cancer sur-
vivors, although the body of evidence is primarily limited to
short-term studies of 12 to 16 weeks’ duration among breast
cancer survivors. Approaches are typically clinic-based or
home-based (eg, telephone counseling, print, Web, social
media). In general, stronger outcomes are associated with
clinic-based programs, whereas greater reach and reduced
participant burden are associated with home-based inter-
ventions.96 However, this generalization is affected by the
motivation of the cancer survivor; as shown by data from
the LEAN (Lifestyle, Exercise, and Nutrition) study,
which found no differences in effects between the modes of
delivery.30 On-site, clinic-based programs are generally
supervised by exercise professionals and tend to have higher
exercise intensity dose and closer supervision and
monitoring. Home-based programs tend to promote
CA CANCER J CLIN 2017;00:00–00
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moderate-to-light PA, reach individuals who cannot travel or
meet the scheduling requirements of on-site programs, are
more likely to be theory-based, and are less costly.97 How-
ever, supervision for home-based programs may be minimal,
so individuals with significant comorbidity or safety issues are
generally excluded. More recently, hybrid programs that are
able to support sustained PA have emerged. Generally, these
programs begin with an on-site, supervised phase and then
taper to an off-site phase (eg, the CHALLENGE trial).21
A review of behavior change studies, including a meta-
analyses of 14 RCTs among breast cancer survivors,98 found
that the key elements of effective interventions are self-
monitoring of PA, individualized guidance or coaching, and
setting clear goals and expectations. Because PA mainte-
nance may be particularly challenging with long-term (eg,
fatigue) or later effects of cancer treatment (eg, arthralgia),
attention to symptom management (which ideally starts as
prehabilitation and continues across the cancer survivorship
trajectory) may be an important consideration to optimize
PA uptake and adherence long term.21,99 Likewise, there is
potential for interventions (especially PA) to reduce these
symptoms and thus contribute to the survivor’s ability to
maintain healthy behavior changes over time. Given that
obesity may adversely affect adherence to PA regimens, there
is a need to determine the relative timing or sequence of PA
in relation to caloric restriction within the context of weight
management.73,100 As indicated above, research is needed to
determine what type of PA works (modality [eg, aerobic,
strength], intensity, frequency, and duration) to achieve
which outcomes and for whom,101 as well as when in the
course of the cancer continuum programs should be offered.
Identifying the minimal PA dose for QOL improvements,
weight and symptom management, and survival will assist in
developing pragmatic programs that target outcomes rele-
vant to patients’ needs (eg, management of fatigue and pain).
Looking ahead, improvements in the recovery and func-
tioning of the growing numbers of cancer survivors may
emerge from use of behavior change theories to inform
intervention development, use of information technology
and mHealth technologies to widen the reach of programs,
plans for maintenance of behavior change, and assessment
of program costs. There are numerous missed opportunities
for health care professionals in oncology and primary care
settings to promote PA for their patients at various points
across the cancer care continuum. Addressing the barriers
faced by providers96,102 and providing guidelines to help tri-
age patients to effective programs (eg, clinic-based, commu-
nity-based, or home-based) are sorely needed.
Summary
Research in the general population has demonstrated the
benefits of weight management and PA for the prevention
and management of diabetes and other chronic diseases,
reducing disability, and delaying mortality. As research on
weight management, PA, and cancer survivorship moves
beyond small, early clinical trials that evaluate the effects of
these interventions on biomarkers and QOL, larger trials
are needed to test the effects of the interventions on
disease-free and overall survival, especially in disease sites
other than breast cancer, and to include adequate represen-
tation of population subgroups defined by comorbidity/
functional status, race, ethnicity, or age. To ensure that clin-
ical trials are appropriately designed to provide more defini-
tive answers, the NIH has recently established new
guidance related to funding applications submitted to the
NIH for all clinical trials.103 Specific institutes, such as the
National Cancer Institute, have used expert working groups
to discuss trial design issues within their clinical trial net-
works, including those related to behavioral interventions.
Within the NIH Obesity Research Task Force, the
National Heart Lung and Blood Institute is leading an
effort to identify additional factors that may predict success-
ful response to weight management interventions. The
Accumulating Data to Optimally Predict obesity Treatment
(ADOPT) Core Measures Project was developed in
response to the well documented individual variability in
response.104 ADOPT is designed to provide investigators
with tools to generate an evidence base that may advance
understanding of the behavioral, psychosocial, environmen-
tal, and biologic sources of this variability. Working with an
expert panel of investigators, a trans-NIH group identified
an initial core set of high-priority measures that, when con-
sistently used in trials, may facilitate the prediction of treat-
ment response. The NIH is now exploring approaches for
increasing the use of consistent measures across trials so that
data can be pooled and used to identify reliable predictors,
mediators, and moderators of response. This accumulation
of efficacy evidence will likely spur the translation of effec-
tive interventions into clinical practice, although research in
implementation science also is needed to best adapt inter-
ventions to enhance their reach, scope, and uptake among
populations and settings that may not be representative of
clinical trials.
Addressing the Weight Management and PA
Needs of Diverse Populations of Cancer Survivors
Low-income, minority populations, particularly African
Americans and Hispanics, as well as those who are older
and live in rural areas bear a disproportionate burden of
cancer.7,105-107 Moreover, these populations also are more
likely to be overweight or obese, physically inactive, and
to manifest health conditions that are affected by these
factors, such as metabolic syndrome—all of which are
associated with greater comorbidity and reduced survival
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VOLUME 00 _ NUMBER 00 _ MONTH 2017 11
(overall and cancer-specific). This section addresses weight
management and PA among diverse populations.
Meeting the Needs of Diverse Survivors in Terms
of Race/Ethnicity, Culture, and Language
Among cancer survivors, prevalence of overweight and
obesity is high, especially among non-Hispanic blacks and
Hispanics compared with non-Hispanic whites.108 Concor-
dantly, cancer survivors who are members of minority groups
have lower adherence to diet and PA guidelines and are
more likely to report poorer health status compared with
nonminority cancer survivors or racial/ethnic minorities
without cancer.109-115 Thus, there is a critical need to
develop and examine weight management and PA interven-
tions among cancer survivors of racial/ethnic minority status
to enhance outcomes and reduce disparities. Consideration
of patients’ environmental, cultural, and survivorship context
is critical to the success of these efforts.116 Racial and ethnic
minority survivors are more likely to live in areas character-
ized by high segregation, traffic density, and crime and by
low neighborhood socioeconomic status and access to full-
service supermarkets and PA resources.117-119 Despite this,
most communities, including lower socioeconomic neigh-
borhoods, also have some assets, such as farmers’ markets,
public recreation systems, and community gardens that sup-
port PA, healthy eating, and reduction of chronic dis-
ease.120-122 Partnering with community organizations to
bring interventions to under-resourced neighborhoods pro-
vides opportunities to build social capital, reach more cancer
survivors, and increase potential for sustainability.123
Consideration of cultural norms is important. Culture
varies among and within racial and ethnic groups, influenc-
ing beliefs, behaviors, and patient-provider interactions
related to cancer, obesity, and lifestyle. The conceptual
framework of Kreuter et al124 can inform cultural tailoring
and structure formative work, thereby enhancing the rele-
vance of an intervention approach and content to a particu-
lar population (see Table 4).124 Similarly, because cancer
survivors report greater interest in programs that
acknowledge their cancer journey and concerns, it is impor-
tant for programs to address these issues.125 In addition to
context, biopsychosocial approaches to research are needed
to understand and address the multilevel factors (from cells
to society) that affect weight status and behavior and influ-
ence cancer control, overall health, and QOL.107
To date, weight management and PA interventions
among racial/ethnic minority cancer survivors have estab-
lished feasibility and safety and report positive, albeit mod-
est, results, including weight loss, behavioral changes,
improved QOL and biomarker status, and decreased
cancer-related anxiety.84,87,88,90,126-133 Limitations of many
studies include quasi-experimental designs, small sample
sizes, a focus on behavioral outcomes, and sole inclusion
of breast cancer survivors. Only 3 studies assessed bio-
markers,87,90,128 and only one targeted a cancer other than
breast134—none included men. Recent efforts address some
of these limitations.135,136 Important steps to advance the
science of obesity and lifestyle interventions in diverse popu-
lations include using more rigorous methodologies, address-
ing multilevel mediators and moderators of change,
examining biologic mechanisms related to energy balance
and cancer, and addressing more diverse cancer survivor
populations.
Meeting the Needs of Cancer Survivors Across the
Lifespan
Currently, 62% of cancer survivors are age 65 years and
older—a subpopulation that will continue to grow with
the aging of the population along with earlier diagnosis
and improvements in treatment.137 However, cancer also
affects the young. In the United States, there are almost
400,000 childhood cancer survivors and 70,000 adoles-
cent and young adult cancer survivors, many of whom
could have long lives ahead of them.137 Lifestyle inter-
ventions are sorely needed by survivor populations of all
age groups, because suboptimal diets and insufficient PA
are noted in 40% to 70% and 54% to 84% of younger can-
cer survivors, respectively,138-141 and in 52% to 85% and
TABLE 4. Framework to Guide Cultural Tailoring of Behavioral Interventions (Kreuter 2003124)
DOMAIN ACTION
Peripheral Design study materials to appear culturally appropriate (ie, logo, recruitment materials)
Evidential Enhance relevance of targeted health issues by presenting evidence of their impact
(ie, cancer disparities, impact of obesity, comorbidity burden)
Constituent-involving Draw directly on the experiences of the target group (ie, staff represent target group; inform intervention
using qualitative data from target population; engage advisory group to provide feedback on study materials and procedures)
Sociocultural Discuss health-related issues in the context of broader social and/or cultural values (ie, role of God and faith in one’s
daily life, woman’s central role in families, cancer fatalism and stigma, body image ideals, and the traditional roles of food)
Linguistic Make health education programs and materials more accessible by providing them in the dominant or native language of target group
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53% to 70% of older cancer survivors, respectively.142-144
In addition, up to 71% of older cancer survivors are over-
weight or have obesity, and these conditions also are
prevalent in children, adolescents, and young adults diag-
nosed with acute lymphocytic leukemia and some forms
of brain cancer.140,142
A unifying theme shared by both young and old cancer
survivors is that of the long-term and late effects of cancer
and their treatment, many of which are influenced by nutri-
tional status and PA,145 such as increased risk of CVD, sec-
ond cancers, osteoporosis, metabolic syndrome, fatigue,
cognitive changes, and sarcopenia. Underlying many of
these conditions is the process of accelerated aging and
frailty among cancer survivors, which occurs across all age
groups.
Frailty, or an “insufficient reserve to recover,” is generally
preceded by diminished function,146 both of which increase
with age. However, illnesses and injury, as occur with cancer
and its treatment, accelerate this course, especially among
females.145 Other factors, such as a poor diet, physical inac-
tivity, and obesity, further exacerbate functional decline and
the onset of frailty.147 Current data indicate that the odds of
frailty are significantly increased among individuals with a
BMI of 30 kg/m2 or greater (odds ratio, 1.12; 95% CI,
1.01-1.19 [P 5 .003]).148 Weight management and PA
interventions can potentially reorient neuromuscular con-
trol, increase muscle strength, and reduce frailty.33,60,61,149
Despite the potential benefits of weight management to
forestall frailty and common comorbidities, caution is
needed in pursuing weight loss. Until more data are avail-
able specifically on cancer survivors, the AHA/ACC/TOS
and National Heart Lung and Blood Institute guidelines
can inform best practices.54,150 Among these guidelines is
the recommendation for a rate of weight loss of 1 to 2
pounds per week. Because sarcopenia is a common condi-
tion that accompanies cancer and its treatment and one that
accelerates aging, slower rates of weight loss that minimize
LBM loss, concurrent with strength training, are recom-
mended.151 For older adults, weight loss guidelines suggest
an energy deficit of 500 to 750 kcal daily to promote a
weight loss of up to 1.5 pounds per week152; for childhood
and adolescent cancer survivors, energy deficits of up to 250
kcal per day to invoke a maximum weight loss of 0.5 pounds
per week are recommended.153 Also, behavioral approaches,
such as substituting higher energy with lower energy density
foods, avoiding distracted eating, and adopting slower rates
of eating, are commonly used tactics to help prevent weight
gain in adults and allow children to “grow into their
weight.”
Regular PA is important for cancer survivors of any age
to achieve optimal health. Thus the avoidance of inactivity
is key, and adaptations need to be made to accommodate
limitations or comorbidities because of cancer or its treat-
ment.24 Guidelines suggest that children pursue 300
minutes per week of moderate to vigorous PA, whereas the
guidelines for adults (including older adults) suggest 150
minutes of moderate PA or 75 minutes of vigorous PA per
week.25,154 Strength training 2 or 3 times per week is rec-
ommended across the lifespan25,154; although, for children,
this recommendation is made within the context of a sports
curriculum and with adequate supervision.155 The benefits
of low-intensity PA have recently been reported as well;
however, to date, there are no guidelines in this area.156 The
means by which weight management and PA are promoted
in younger versus older cancer survivors differs.157-161 For
example, children have preferences for game-based or play-
based interventions, whereas older adults favor holistic
interventions (eg, gardening, dancing) that have personal
meaning and/or involve others. Because of prevalent func-
tional and sensory deficits among the young and the old, it
is critical that interventions use large font (and screen size),
volume control, module brevity, pretraining, and support for
new technologies, especially those that allow for home-
based delivery.162 Exemplar interventions are featured in
Table 3.91,93,163 In addition, given the key role that care-
givers play in the lives of children and older adults, an unex-
plored area with potential is the use of dyadic approaches.
Meeting the Needs of Rural Cancer Survivors
Rural cancer survivors (ie, those residing in nonmetropolitan
counties, as defined by the Office of Management and Bud-
get)164 have higher cancer mortality rates compared with
urban residents across all regions of the United States.
Moreover, death rates from cancer have declined at a slower
rate in rural compared with urban counties.165 Among can-
cer survivors, those from rural areas report poorer health sta-
tus, more psychological distress,166 higher rates of depression
and anxiety,167 and greater knowledge gaps related to their
cancer and its treatment effects. Rural cancer survivors also
report high levels of unmet support needs.168 These dispar-
ities are compounded by higher rates of comorbidities, obe-
sity, and physical inactivity among rural compared with
urban residents.169-172
Rural cancer disparities affect a significant proportion of
our population. Nearly 20% of Americans,173 and an esti-
mated 21% of cancer survivors, reside in a rural area, repre-
senting roughly 2.8 million survivors.166 Rural residents are
a diverse group. Nationwide, 78% of rural residents are
non-Hispanic white; however, higher proportions of Afri-
can Americans and Hispanics reside in the south and south-
west, respectively. Despite their diversity, rural residents
often share common cultural elements, such as conventional
attitudes, self-reliance, and orientation toward work, family,
and religion.174 Rural residents of all racial/ethnic groups
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are also older, poorer, and have less education than their
urban counterparts.161 These demographic differences, in
addition to the contextual, cultural, and access factors stem-
ming from place of residence, contribute to rural cancer dis-
parities.175 All of these factors need to be considered when
designing lifestyle interventions for rural cancer survivors.
Effective, remote-based interventions are essential to
maximize reach into rural communities because of chal-
lenges with access to health care services (including special-
ized services for weight management and PA), travel time,
and financial barriers. With approximately 3% of medical
oncologists176 and very few specialized psycho-oncology
providers practicing in rural communities, there is a gap in
services for supportive care and lifestyle interventions.177
Travel time and transportation costs pose barriers for in-
person lifestyle interventions, particularly in frontier regions.
Survey results among rural breast cancer survivors in Kan-
sas and Illinois found that the vast majority did not met PA
guidelines178 but rated PA and weight management pro-
grams as a top need.179 To date, there is only one published
trial of a full-scale lifestyle intervention done exclusively in a
rural setting. Befort et al180 enrolled 210 breast cancer survi-
vors into a 6-month telephone-based intervention delivered
by a weekly conference calls. The study demonstrated feasi-
bility and achieved a 12.9% weight loss—with a 10.6% net
loss maintained at 18 months—through continued, but
scaled back, conference calls. Lessons learned from that
study are needs for: 1) direct patient recruitment through
cancer registries (direct mailing yielded 84% of participants,
whereas physician referrals yielded only 4%); 2) clinical inte-
gration (because of high levels of comorbid conditions); and
3) group support among rural women.181 While the inter-
vention was exclusively home based, many participants
arranged to meet in person with one another; therefore,
some face-to-face contact may enhance intervention efficacy
for some and needs to be considered in future programming.
Additional research also is needed to better understand
environmental determinants of diet and PA in rural areas
and contextual factors influencing successful implementa-
tion across various health care and community settings.
Summary
Overall, there are limited data available on the effectiveness
of weight management and PA interventions for diverse
populations, although feasibility and safety have been estab-
lished. In each unique population, various factors must be
addressed to ensure that weight management, PA, and
behavioral modification elements address physiologic needs
and health issues (eg, promoting slower weight loss among
pediatric and geriatric cancer survivors who are at greater risk
for stunting and sarcopenia, respectively), individual prefer-
ences (eg, home-based delivery to overcome travel barriers),
and community-based resources (eg, partnering with
community-based organizations for program implementa-
tion). Given the higher prevalence of overweight and obe-
sity and suboptimal lifestyle practices among certain
subpopulations of cancer survivors (eg, racial/ethnic minor-
ities, those residing in rural areas, pediatric and older cancer
survivors) there is a need to target interventions to these
diverse populations that are currently more likely to have
poorer outcomes and shorter years of survival.
Opportunities and Challenges for the
Workforce, Care Coordination, and
Technologies to Support Weight Management
and PA in Cancer Survivors
Several factors currently limit the ability to deliver weight
management and PA programs to all cancer survivors who
need them. These barriers exist at multiple levels. Barriers at
the level of the cancer survivor and family have been covered
in the sections above and include factors such as high costs,
lack of geographic access to these programs, or lack of
knowledge or motivation of how to change health behaviors.
These may be compounded by barriers at the level of the cli-
nician, such as lack of clinician comfort with discussing
weight with patients or lack of knowledge of which inter-
vention to refer or prescribe, as well as competing demands
for time in the clinical encounter. Finally, barriers at the
level of the health care system and the environment present
further challenges; for example, a lack of prioritization of
PA, weight management, or disease prevention in general; a
lack of insurance coverage for lifestyle change programs; or
the obesogenic environment. These challenges and current
strategies to overcome them are described below.
Weight Management and PA: Clinical Care
Opportunities and Challenges
A health care professional’s recommendation to exercise sig-
nificantly improves PA engagement,96,182 yet many pro-
viders do not counsel patients who might benefit on the
need for PA or weight management. Research shows that
providers are more likely to encourage a change in health
behavior if they have established a positive patient-physician
relationship, have available referral resources to facilitate
health behavior change, and believe that health behavior
engagement will benefit cancer outcomes or overall health
and well being.183 Several individual and systems barriers
need to be overcome to promote PA and weight manage-
ment in the delivery of survivorship care. Competing time
demands during oncology visits dictate that oncology care
providers help patients make difficult choices about therapy,
monitor side effects, promote adherence to oral medications,
administer screening evaluations, and help patients cope
with the psychological effects of cancer diagnosis and
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treatment, presenting significant obstacles to discussions of
PA and weight management.183-186 Moreover, in the cur-
rent age of electronic medical records, health care professio-
nals in general spend only one-half of their scheduled clinic
visit time talking with the patient and over one-third of
their time on documentation.187 Furthermore, most health
care professionals do not receive adequate training in how to
operationalize health behavior recommendations at the level
of an individual patient,185 so a generalized lack of expertise
or competency in knowing what and how to recommend
changes is a major barrier. Providers also need resources for
appropriate services (eg, dietitians, exercise specialists, or
programs)183,188,189; but a lack of supportive infrastructure,
including lack of access to appropriate referrals or effective
strategies as well as limited insurance coverage, can inhibit
provider recommendations.184,185 Care providers also may
be skeptical that a cancer survivor can change behavior or
may worry that engaging in weight management or PA dur-
ing or after treatment may be risky to the survivor’s overall
health.183 Finally, a lack of knowledge about the benefits of
weight management and PA can result in a lack of motiva-
tion to focus on this topic.183 Fortunately, there are several
resources available for cancer survivors and health care pro-
fessionals to help promote weight management and PA (see
Table 5).
Overcoming Workforce Issues and Establishing
Common Competencies
The contribution of excess weight and physical inactivity to
cancer and overall health outcomes emphasizes the need for
health professional education and adoption of appropriate
competencies. The lack of a standard of care for overweight
and obesity and its associated lifestyle factors, the mismatch
of disease burden with care provider capacity, and the lack
of integrated clinical and community services constitute
major barriers to effective care. Behavior change is the cor-
nerstone of therapy. For the care of pediatric patients with
obesity, the USPSTF recommends moderate-to-high–
intensity behavioral interventions, including nutrition, PA,
and behavioral counseling for a minimum of 26 contact
hours.190 For adults with obesity, the USPSTF recommends
obesity behavioral interventions that include self-
monitoring and from 12 to 26 visits over the course of a
year.51 However, few providers have been trained in the
delivery of behavior change therapies; and, currently, few
major insurance plans provide reimbursement for the dura-
tion of care recommended by the USPSTF.
A second gap is the lack of understanding of the most
fundamental elements of obesity care. For example, less
than 50% of internists, family practitioners, obstetricians/
gynecologists, and nurse practitioners surveyed knew the
TABLE 5. Resources for Weight Management and Physical Activity
ORGANIZATION RESOURCES AVAILABLE WEB SITE TELEPHONE
American Cancer Society Survivorship guidelines (nutrition and
physical activity; cancer-specific)
cancer.org (800) 227-2345
American College of Sports Medicine Physical activity guidelines for exercise
professionals
acsm.org (317) 637-9200
American Institute for Cancer Research Health behavior information and
recommendations
aicr.org (800) 843-8114
American Physical Therapy Association/
The Oncology Section
Physical activity and safety consider-
ations for the cancer survivor
apta.org (800) 999-2782
American Society of Clinical Oncology Survivorship Compendium, Obesity
Toolkit
asco.org (571) 483-1300
Cancer Nutrition Consortium Nutrition Guidance cancernutrition.org (857) 301-8495
LIVESTRONG Health behavior tools, LIVESTRONG at
the YMCA
livestrong.org (855) 220-7777
National Cancer Institute/Office of
Cancer Survivorship




National Center for Health Promotion &
Disease Prevention/VHA




guidelines for health care providers
nccn.org (215) 690-0300
National Heart, Lung, and Blood
Institute
Weight management resources nhlbi.nih.gov (301) 592-8573
Silver Sneakers Physical activity for older adults silversneakers.com (866) 584-7389
Abbreviation: VHA, Veterans Health Administration.
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recommended level of PA for adults, and even fewer knew
the USPSTF guidelines for treatment of obesity. Similar
surveys have not been administered to oncology care pro-
viders; however, their knowledge in these areas is not likely
to be better.
To address these gaps, 24 organizations involved in the
care of obesity convened to develop common competencies
for the prevention and treatment of obesity.191 This effort,
funded by the Robert Wood Johnson Foundation, led to the
development of 10 major competencies, which are shown in
an abbreviated form in Table 6.192 The consensus-derived
competencies are not intended to be an obesity curriculum.
Rather, the expectation is that each of the groups involved in
their development will adapt them to the needs of their spe-
cific profession; however, a limitation is that oncology was
not represented among these groups.191
A final issue is the need for providers to be sensitive to
the issue of stigma and bias. The stigma associated with
obesity may be secondary only to race.193,194 Because obesity
is so highly stigmatized, providers who are uncomfortable
with the topic and unaware of how to discuss it with their
patients often add to this burden.193 Consequently, patients
with obesity may not receive the care they need. Therefore,
the competencies include understanding terms that are
acceptable to patients in discussions about weight and the
need for joint decision making with respect to care.
Opportunities and Challenges Posed by New
Technologies
Self-monitoring is a strong predictor of weight management
success,195 but engagement with self-tracking declines over
time.196 New technologies have improved adherence over
traditional paper modes, and pairing feedback with tracking
optimizes behavior change.196 However, the challenges of
maintaining self-monitoring of diet and PA remain. Daily
weighing, via an internet-connected scale paired with text
message feedback, has been found to promote clinically
meaningful weight loss of 6% within 6 months in healthy
populations.197 These data suggest that self-monitoring
strategies that are both discrete and simple achieve high
engagement and desired clinical outcomes. However, mobile
application (app) abandonment rates have been well docu-
mented in commercial and research settings.198,199 Such data
indicate that multiple strategies (including Web, e-mail,
interactive voice response, and text messaging) are needed to
keep users connected to feedback or coaching and are neces-
sary to complement self-monitoring strategies—strategies
that may vary by population subgroup. Current research
shows that feedback strategies that are real-time responsive
(eg, app messages) are better positioned than those that are
delayed (eg, weekly coaching calls), but there is a need to
better understand the reasons why users disengage from
technology. Moreover, while technology is currently used to
address data collection, analytics, and integration with a goal
of providing actionable feedback to users, the integration
with health care professionals to provide health care decision
support has yet to be made and is a needed leap.
Summary
The considerable body of research on weight management
and PA interventions has documented myriad positive
effects during and after cancer care. Despite the numerous
challenges in delivering weight management and PA pro-
grams for cancer survivors, this is a time of unprecedented
opportunity to include these programs as part of standard
cancer and follow-up care. Several national trends and
changes in health care are contributing to this opportunity
while addressing some of the multilevel barriers to deliver-
ing these programs. At the level of the survivor and family,
it is clear that engaged and activated patients participate
more fully in their health care. Thus, efforts by clinical and
public health groups have focused on patient activation and
education about the importance of weight management and
PA. Examples of this are patient education materials avail-
able on the websites of ASCO, the American Cancer Soci-
ety (ACS), and the National Cancer Institute, as well as the
Springboard Beyond Cancer mobile health tool (survivor-
ship.cancer.gov) and SurvivorSHINE (survivorshine.org)
websites, which help survivors change their lifestyle behav-
iors along with managing their ongoing symptoms and self-
managing their health. The latter are examples of another
ongoing trend discussed above: using technology to increase
the feasibility of delivering interventions to survivors regard-
less of location. Technological solutions also may help
reduce financial barriers to these programs for survivors who
have limited economic resources.
At the level of the health care professional and clinical
practice, there are now multiple guidelines from the ACS,
ACSM, ASCO, NCCN, and others delineating weight
management and PA as part of overall cancer care and
follow-up care. The work described above, to establish weight
management competencies for clinicians, will help increase
TABLE 6. Competencies for Health Care Professionals
in Obesity Prevention and Control (Bipartisan
Policy Center 2017192)
Understanding the framework of obesity as a medical condition
Knowledge of epidemiology and key drivers of the epidemic
Knowledge of disparities and inequities in obesity prevention and care
Providing interprofessional obesity care
Integration of clinical and community care for obesity
Use of patient-centered communication
Recognition and mitigation of weight bias and stigma
Accommodation of people with obesity
Use of strategies for patient care related to obesity
Recognition of acute warning signs of obesity complications
Weight Management and Physical Activity Throughout the Cancer Care Continuum
16 CA: A Cancer Journal for Clinicians
the ability of the clinical workforce to deliver appropriate
care. In addition, health care professionals need safe and effi-
cacious programs available for patient referral and time dur-
ing the clinical encounter to discuss these issues and resources
with patients and survivors. Interventions in community set-
tings, such as LIVESTRONG at the YMCA, the availability
of ACSM-certified Cancer Exercise Trainers in gyms across
the country, and other programs for cancer survivors are help-
ing to provide sources for appropriate referral.
Finally, changes in American health care present an oppor-
tunity to integrate weight management and PA programs
into cancer and follow-up care. The transition from fee-for-
service to value-based payment models is also bringing atten-
tion to identifying interventions that are “good buys” (ie, that
result in positive effects in multiple ways, in terms of patient
outcomes and cost savings). The multiple positive effects of
weight management and PA on overall health, well being,
and QOL are prompting health care funders and decision
makers look more seriously at these interventions.
Weight Management and PA Programs for
Cancer Survivors: Models of Care
Successful incorporation of PA and weight management
services into cancer survivorship care requires effective mod-
els of care delivery services. Because survivors come with a
range of needs and preferences for services, oncology health
care professionals need algorithms for assessing these factors
to triage survivors and refer them to appropriate programs.
Guidelines for providing smoking-cessation assistance in pri-
mary care settings use a schema that may prove useful in
conceptualizing this process; the 5 As (Ask if a patient is
smoking, Advise quitting, Assess patient motivation for
making a quit attempt, Assist with counseling referral and
pharmacotherapy, and Arrange follow-up within a week of
quit date).200
Ask/Advise
Referral of cancer survivors to PA and weight management
services starts with a conversation between the health care
professional and their patient about these issues. A survey of
15,254 cancer survivors in the United Kingdom found that
survivors who recalled a conversation with their care provider
about exercise were 88% more likely to be physically active
and to meet PA recommendations201; however, only 31% of
the respondents recalled such a conversation. In the US, dis-
cussion about PA is documented in only 35% of patient-
oncologist encounters.202 Therefore, provider prompts may
enhance discussions on this topic within the workflow and
need to be considered in models of care delivery.
Assess
Cancer survivors have a range of needs and limitations
regarding their symptoms, physical limitations, and comor-
bid health conditions that need to be considered. A process
for assessing these conditions is necessary to determine opti-
mal programs for weight loss or PA to ensure appropriate
supervision and patient safety. At the same time, the cancer
survivors’ goals, preferences, and prior experience with PA
and weight management need to be considered. The
ACSM health screening guidelines, which take into account
the patient’s current activity level, signs and symptoms of
disease, and desired intensity of exercise, are used to assess
capacity for PA in the general population and may be useful
to implement for cancer survivor populations.203 Figure 1
provides an example of how survivor goals and preferences
might interact in recommending an exercise program for a
breast cancer survivor at risk for lymphedema.
Assist (or Refer)
Few clinical practices providing oncology/survivorship care
are able to provide PA and weight management services and
FIGURE 1. Example of Tailoring an Exercise Program to the Patient’s Physical Needs and Preferences.
CA CANCER J CLIN 2017;00:00–00
VOLUME 00 _ NUMBER 00 _ MONTH 2017 17
often require referral to outside programs. There are growing
numbers of programs available; some are cancer specific (eg,
LIVESTRONG at the YMCA), but programs intended for
the general population may also be appropriate (eg, Silver
Sneakers). In addition, home-based or self-directed pro-
grams that rely on books and other print material, websites,
mobile apps, and wearable devices (like pedometers and
connected activity monitors and scales) can assist cancer sur-
vivors with PA and weight management. Cancer survivor-
specific versions of such programs have shown efficacy in
research studies but are not widely available outside of the
research setting. Cancer survivors who have physical limita-
tions or comorbid medical conditions may need to start with
a clinic-based program, such as a cancer rehabilitation pro-
gram or a medical weight-loss program. A challenge for
health care professionals is knowing which programs are reli-
able and of high quality for cancer survivors. There is a need
to develop and refine program standards and staff certifica-
tion to optimize safety and effectiveness.
Connect
Even if effective programs are available, there often is a need
to motivate cancer survivors to follow up on recommenda-
tions to access services. Research on smoking cessation shows
that placing the onus of contact on the service provider
(assuming that the patients’ permission is obtained to share
their contact information) can boost enrollment by 13-fold
to 30-fold.204,205 A similar connection strategy could be used
by an oncology clinic referring patients to programs like
LIVESTRONG at the YMCA or cancer rehabilitation.
Cancer survivors need access to a variety of safe and effec-
tive programs and clinical services to assist them with
increasing PA and managing their weight. In addition,
there also is a need to increase provider competencies;
develop tools to assist providers; and build capacity in work-
flow and procedures that increase the likelihood that the
patient-provider discussion about weight management and
PA transpire, that referral to appropriate programs that are
aligned with survivors’ needs and preferences occurs, and
that follow-through takes place.
Exemplar Programs
Over the past 2 decades, and with increasing recognition of
the heightened needs of cancer survivors for supportive care to
improve both emotional and physical health, several PA and
weight management interventions have been developed and
tested. Brief descriptions of some of these exemplars follow:
MOVE!
In 2006, the Veterans Health Administration implemented the
MOVE! Weight Management Program for Veterans,206 an
evidence-based comprehensive lifestyle intervention available to
veterans receiving care at all Veterans Health Administration
medical centers. MOVE! assists veterans who are overweight
or have obesity and an obesity-associated condition, such as
cancer or CVD, to achieve clinically significant weight loss.206
The program adheres to evidence-based recommendations
from the Department of Veterans Affairs/Department of
Defense Clinical Practice Guideline for Screening and Man-
agement of Overweight and Obesity,207 which provides flexi-
bility in addressing the unique needs of cancer survivors. The
Department of Veterans Affairs/Department of Defense guide-
line recommendations include: yearly screening and documen-
tation of overweight/obesity; pharmacotherapy and bariatric
surgery as adjuncts to comprehensive lifestyle intervention;
shared decision-making among providers and patients to sup-
port patient engagement based on individual values and prefer-
ences; and repeated assessment of response to treatment, with
adjustments as needed to ensure clinically meaningful weight
change. MOVE! and weight management care are embedded
within the health care system while also supporting care coordi-
nation across primary and specialty care settings (including
oncology) and inpatient and outpatient care.
LIVESTRONG at the YMCA
Over the past decade the YMCA, which consists of a
national resource center (YMCA of the USA, or Y-USA)
and over 2700 local YMCAs, has partnered with many pub-
lic health and health care stakeholders to transform its net-
work to better serve the health of the nation. Local YMCAs
are trained to build their capacity and to develop competen-
cies needed to become a strong partner. Thereafter, they are
licensed to deliver standardized programs and services for
those with special health needs (eg, the YMCA’s DPP for
people with prediabetes, Healthy Weight and Your Child
for families with children who are challenged by obesity,
etc). To address the challenges faced by cancer survivors,
Y-USA partnered with the LIVESTRONG Foundation to
develop and scale a 12-week PA program.
The program model was nested within a 6-month organi-
zational change process modeled after the Institute for
Health Care Improvement’s “Plan, Do, Study, Act.” Local
YMCAs that have an interest in serving cancer survivors
within their communities are encouraged to submit a readi-
ness assessment to Y-USA. The LIVESTRONG Founda-
tion, the local YMCA leadership, and, more recently, the
Centers for Disease Control and Prevention have supported
YMCAs that demonstrate the highest levels of commitment
to go through the organizational change process and
become trained and authorized to deliver the LIVE-
STRONG at the YMCA program. Through the organiza-
tional change process, YMCA staff build competencies,
such as those related to understanding cancer survivors’
needs, providing welcoming environments, and developing
partnerships with local cancer centers and oncology health
care professionals.
Weight Management and Physical Activity Throughout the Cancer Care Continuum
18 CA: A Cancer Journal for Clinicians
Data indicate that the program leads to significant
improvements in PA, stamina, and QOL208; and it has been
scaled to over 500 locations in 39 states, serving nearly
50,000 cancer survivors. Currently, philanthropy is required
to make this program free of charge to all cancer survivors,
and wait lists have been established in cases where demand
exceeds availability.
In 2016, Y-USA completed a claims-based cost-savings
demonstration of the YMCA’s DPP that led to Medicare
coverage of that program.209 A partnership between Y-USA
and the Robert Wood Johnson Foundation was instrumen-
tal in transforming the systems behind scaling and sustain-
ability that produced health outcomes and value within the
health care system. Connections were made between the
electronic medical record system of health care organiza-
tions and local YMCA business units. Health care providers
are increasingly referring patients to programs like LIVE-
STRONG at the YMCA under alternative payment models
(eg, Accountable Care Organization [ACO] structures or
bundled payment models) in which the value and savings of
these programs are reinvested in partnerships with the
YMCA, and payers are providing coverage for the YMCA’s
DPP under claims-based reimbursements.
The Physical Activity and Lymphedema and Strength
After Breast Cancer trials
The challenge of knowing which cancer survivors can be
safely referred to home-based and community-based exer-
cise remains unresolved,210-212 although initiating exercise
programming within the context of outpatient rehabilitation
clinics is a potential approach. The Physical Activity and
Lymphedema (PAL) trial was revised to use this approach
among breast cancer survivors after establishing the safety
and efficacy of a weight-lifting intervention for lymphedema
and other side effects of cancer and its treatment.32,41,213-220
The PAL intervention was originally implemented in select
YMCAs in which fitness staff received training (including
preintervention safety evaluations) and ongoing support
from PAL investigators. Because of high staff turnover at
the YMCAs, concern about implementing safety evalua-
tions, and an unwillingness of participants to continue to
pay for YMCA memberships, this program led to the crea-
tion of “Strength After Breast Cancer”—a dissemination
and implementation study to translate PAL into the setting
of outpatient rehabilitation.221
As noted in other effective interventions, the “Strength
After Breast Cancer” intervention optimally begins with a
referral by the oncology/primary care provider to the outpa-
tient rehabilitation clinic, which then contacts the patient.
Clinic staff implement a safety evaluation, then deliver an
educational session on lymphedema, as well as 4 sessions of
weight-lifting instruction, before release to a home-based
program. Favorable comparison of the efficacy of this
revised program with the original PAL trial led to an online
continuing-education course that targets outpatient rehabili-
tation specialists (klosetraining.com/course/online/strength-
abc).221 Over 400 outpatient rehabilitation clinicians have
completed the course, and no difficulties have been reported
in obtaining third-party payer reimbursement.
Healthy Living after Cancer
Healthy Living after Cancer (HLaC) is a partnership pro-
ject among 4 Australian state-based Cancer Councils, which
are funded by the Australian National Health and Medical
Research Council. It is evaluating the implementation of an
evidence-based, 6-month, telephone-delivered lifestyle pro-
gram, delivered by the Cancer Councils through their
national cancer information and support service. HLaC is
provided free of charge to cancer survivors with any type
cancer after treatment with curative intent. It provides
behaviorally based support to achieve internationally agreed
recommendations for PA, healthy eating, and healthy
weight. In this phase 4 dissemination study (single-group,
pre-post design with assessments at baseline and 6 months),
primary outcomes relate to program implementation: adop-
tion (referral sources); reach (number of participants) and
retention; fidelity of implementation; participant and staff
satisfaction; and fixed and recurrent program costs. Second-
ary outcomes are patient-reported and validated measures of
weight, PA, dietary intake/behavior, QOL, cancer-related
side effects, and fear of recurrence. To date, 500 patients
have enrolled (89% women; mean age [6 standard devia-
tion], 55 6 11 years; average BMI [6 standard deviation],
29 6 6 kg/m2), with a wide range of cancers. The retention
(program completion) rate is 57%. Among the first 200 pro-
gram completers, significant (P < .05) and clinically mean-
ingful improvements have been seen in all secondary,
patient-reported outcomes. This collaborative undertaking
provides an opportunity for national dissemination of an
evidence-based intervention to support healthy living
among cancer survivors. Rigorous evaluation of service-level
and patient-reported outcomes will provide the practice-
based evidence needed to achieve sustained support.
Summary
MOVE!, Strength After Breast Cancer, LIVESTRONG at
the Y, and HLaC all serve as model programs that effectively
address the PA and weight management needs of cancer sur-
vivors. These programs, and many others like them, have
established feasibility, safety, and efficacy. Although they are
successful, common challenges, such as referral, training, tri-
age, support, and reimbursement, remain as barriers.
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Insurance Coverage of Weight Management
and PA in Cancer Care
Obesity presents unique challenges in patients with cancer;
however, because of the high prevalence of obesity within
the United States and its association with a constellation of
chronic diseases,222 most payers consider it a general con-
cern across all of their health plan membership. Although
evidence of what works in the treatment of obesity is grow-
ing,54,223,224 the services that are covered and how the cov-
erage is implemented in health benefit plans remain highly
variable. Private and governmental payers of health insur-
ance/benefit plans consider multiple factors as they decide
what to cover and how to implement coverage. While many
consumers and health care professionals assume that cover-
age decisions are based solely on cost, payers generally con-
sider several factors in coverage decisions, including
consumer/employer demand for a service, evidence for
effectiveness and efficiency of the service, the ability to
administer the benefit consistently and fairly, the presence
of state/federal governmental mandates for a service, and
how the benefit will affect the marketability/adverse selec-
tion of a health plan.
In its role as a fiduciary agent for its members, and for
taxpayers in the case of the Centers for Medicare and Med-
icaid Services (CMS), insurers are faced with balancing their
fiscal responsibilities with the mission and values of their
organizations. An insurer first determines whether a service
is effective, and then assesses the impact of that service on
the overall cost of care for the members using that service.
For example, coverage of the previously mentioned Y-USA
DPP was based on relatively short-term data from a CMS
Innovation Center demonstration project that indicated
modest weight loss and significant savings in total costs of
care. However, because the program was projected to reduce
premature mortality, actuarial evaluation suggested that the
program could ultimately lead to higher costs for Medicare
patients who had care needs for a longer period of time. In
response, CMS determined that longer life would not be
considered as a cost (ie, care costs over a longer life span
were zeroed-out). As a result, CMS announced that, in
2018, Medicare would begin reimbursing all DPP programs
that meet CDC requirements.225
Interestingly, as value-based payment systems become
more prevalent for both government and private payers,
issues historically considered within the insurer’s purview
will shift to health care providers who share the financial
risks (eg, next-generation ACOs).226 These payment mod-
els provide payment based on a defined population of con-
sumers and include incentives and potential penalties for
both quality and cost metrics. Private payers, including mul-
tistate Anthem Blue Cross and Blue Shield and most
national health plans, have developed similar value-based
payment models. The expectation is that ACOs, or groups
of physicians, hospitals, and other health professionals who
come together voluntarily to provide coordinated high-
quality care, will provide services that improve the overall
health and well being for a defined set of patients, including
both clinical and community services for the prevention and
treatment of obesity.
Although ACOs currently account for approximately
10% of the private health insurance market, insurers such as
Anthem indicate that up to 60% of their fully insured mem-
bership may be covered under value-based payment models.
The US Department of Health and Human Services has set
a goal of tying 90% of all Medicare fee-for-service payments
to quality or value metrics by 2018.227
Value-based metrics, however, are evolving and incom-
plete. The National Quality Forum has only endorsed 4
screening metrics related to obesity and has yet to reach
consensus on any outcome measures,228 but promising
developments have transpired with Medicare coverage of
the DPP, which includes an outcomes-based payment tied
to both short-term and long-term patient outcomes.
The Bipartisan Policy Center has convened both com-
mercial and government payers to discuss coverage for serv-
ices related to obesity, including an effort to develop a
shared-benefit design. Their discussions have focused on
benchmarks of efficacy and cost effectiveness, in addition to
issues related to member retention, return on investment,
community partnerships, senior leadership support, and
data tracking. Thus health professionals interested in work-
ing with payers to improve coverage for obesity-related serv-
ices need to understand not only the needs of their patients
but also the context in which payers make their coverage
determinations.
Advancing Progress in Tertiary Prevention:
Stakeholder Insights and Recommendations
As cancer treatment advances and survivors live significantly
longer, enhancing health and QOL for cancer survivors has
become a major public health goal—one that also has wide-
spread implications for the financial well being of survivors
and families and of the health care system. Evidence contin-
ues to accumulate strongly suggesting that weight manage-
ment and PA can improve the management of cancer,
comorbid conditions, and QOL. However, there are 3
urgent challenges that must be overcome to connect cancer
survivors with interventions that can ideally help them.
The first challenge is identifying the optimal type of
intervention for a given survivor (eg, specific tumor type,
cultural factors, comorbidities, functional status) and a spe-
cific goal (eg, fatigue management or decreasing risk of
recurrence). This involves research to test varied types of
interventions and to capture multiple types of patient data
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(tumor subtypes, clinical laboratory values, patient-reported
symptom data) in multiple settings (identifying who needs
medically supervised programs vs who benefits from com-
munity programs vs home-based interventions).
The second challenge is identifying how to deliver
evidence-based interventions to support weight manage-
ment and PA, not only in medical settings but also in the
community or through the use of technology. Effective
examples of model programs exist (eg, MOVE!, Strength
After Breast Cancer, LIVESTRONG, and HLaC).
Research is needed to continue to test clinic-based, com-
munity-based, and technology-delivered interventions and
to identify how to facilitate referrals from oncologists and
other health care professionals to these interventions.
Educating health care providers about the importance of
these interventions is a valuable but insufficient step.
Future efforts need to address how to integrate weight
management and PA interventions into standard cancer
care.
The third challenge is accumulating the right data about
weight management and PA programs to inform health
care payer decisions to cover these interventions. Reim-
bursement by insurers will help make these interventions
more affordable for survivors and drive widespread availabil-
ity of these services. Part of this evidence will come from
ongoing trials that will provide evidence regarding the
benefits of postdiagnosis weight management and PA on
recurrence and survival. However, even if these interven-
tions do not specifically affect recurrence, coverage decisions
may be made based on comorbidity management or effects
on downstream health care utilization. Future research
needs to test the cost effectiveness of these interventions on
these important outcomes to inform health care coverage
decisions.
The key to our success in implementing weight manage-
ment and PA programs will be to bridge the silos of exper-
tise, as represented in the NCPF workshop in 2017 in
cancer biology, epidemiology, survivorship, nutrition, PA,
weight management, and economics, as well as health care
systems (eg, ACOs, payers, hospitals, oncology practices),
care providers (eg, oncologists, primary care providers, allied
health professionals, cancer rehabilitation, behavioral medi-
cine) and the community (eg, advocacy organizations,
YMCAs). The efforts to implement effective programs will
need to address individual, provider/workforce, and systemic
barriers, which include barriers specific to cancer survivors
(symptoms and treatment side effects), as well as individual
and cultural differences. The challenge is great. The oppor-
tunities and benefits of collaboration across disciplines and
key stakeholders have significant potential to enhance out-
comes for the growing number of cancer survivors in the
United States and beyond. 
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